psilocybin has been researched along with Altered Level of Consciousness in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hirschfeld, T; Schmidt, TT | 1 |
| Icaza, EE; Mashour, GA | 1 |
| Andrade, KC; Crippa, JA; de Araujo, DB; Hallak, JE; Palhano-Fontes, F; Ribeiro, S; Santos, AC; Tofoli, LF | 1 |
| Kraehenmann, R; Pokorny, T; Preller, KH; Vollenweider, FX | 1 |
| Andel, D; Cahn, BR; Carter, OL; Kometer, M; Vollenweider, FX | 1 |
| Hasler, F; Vollenweider, FX; Wackermann, J; Wittmann, M | 1 |
1 review(s) available for psilocybin and Altered Level of Consciousness
| Article | Year |
|---|---|
Dose-response relationships of psilocybin-induced subjective experiences in humans.
Topics: Behavior Rating Scale; Consciousness Disorders; Dose-Response Relationship, Drug; Hallucinations; Hallucinogens; Humans; Mysticism; Psilocybin; Psychometrics | 2021 |
1 trial(s) available for psilocybin and Altered Level of Consciousness
| Article | Year |
|---|---|
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.
Topics: Behavior Rating Scale; Buspirone; Consciousness Disorders; Double-Blind Method; Ergotamine; Female; Hallucinogens; Healthy Volunteers; Humans; Male; Psilocybin; Serotonin Receptor Agonists; Young Adult | 2016 |
4 other study(ies) available for psilocybin and Altered Level of Consciousness
| Article | Year |
|---|---|
Altered states: psychedelics and anesthetics.
Topics: Anesthetics; Consciousness Disorders; GABA Agents; Hallucinogens; History, 19th Century; History, Ancient; Humans; Psilocybin | 2013 |
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.
Topics: Adult; Banisteriopsis; Connectome; Consciousness Disorders; Female; Gyrus Cinguli; Hallucinogens; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prefrontal Cortex; Psilocybin; Young Adult | 2015 |
The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.
Topics: Adult; Cluster Analysis; Consciousness Disorders; Dose-Response Relationship, Drug; Electroencephalography; Female; Hallucinogens; Humans; Male; Neuropsychological Tests; Occipital Lobe; Parkinson Disease; Perceptual Closure; Photic Stimulation; Psilocybin; Psychometrics; Reaction Time; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Schizophrenia; Serotonin Receptor Agonists; Visual Cortex | 2011 |
Effects of varied doses of psilocybin on time interval reproduction in human subjects.
Topics: Adult; Brain; Cognition; Consciousness Disorders; Dose-Response Relationship, Drug; Female; Hallucinogens; Humans; Judgment; Male; Mental Processes; Psilocybin; Time Factors; Time Perception | 2008 |